High accrual ratio suggests lower profit growth for Rigel Pharmaceuticals as of August 13, 2025.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
High accrual ratio suggests lower profit growth for Rigel Pharmaceuticals as of August 13, 2025.
Keep exploring
Part of
Rigel Pharmaceuticals' stock gain contrasts with the performance of the Zacks Medical sector.Also in this story
- Rigel Pharmaceuticals' stock experienced a Golden Cross on August 7, 2025.
- Rigel Pharmaceuticals, Inc. reported that its Q2 financial results surpassed market expectations.
Coverage
Newest first; wire copies grouped- Simply Wall St.Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality Explore Rigel Pharmaceuticals's Fair Values from the Community and select yours Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) s